Vaccine-makers shrug off concerns about Trump admin cutting corners

Several of the companies, including AstraZeneca, Moderna and Pfizer, have published promising results from early human trials of their vaccine candidates. Of the five firms represented at the hearing, all but Pfizer have received anywhere from hundreds of millions to more than a billion in U.S. government funding for their experimental coronavirus shots. All of […]

from Newslanes https://ift.tt/39itClr